PTGX Operating Expenses

Protagonist Therapeutics Inc · Operating Expenses

PTGX logo

PTGX Operating Expenses

Latest reported$223.24M
PTGX Operating Expenses ($9.32M → $223.24M)
High-resolution chart · PNG

PTGX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Protagonist Therapeutics Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
202,918,000
181,590,000
153,652,000
157,954,000
153,202,000
93,144,000
80,752,000
73,194,000
57,960,000
32,666,000
14,794,000
9,319,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.